Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Common Equity (2023 - 2025)

Hinge Health (HNGE) has disclosed Common Equity for 3 consecutive years, with $178.7 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 141.11% to $178.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $178.7 million through Dec 2025, up 141.11% year-over-year, with the annual reading at $178.7 million for FY2025, 141.11% up from the prior year.
  • Common Equity hit $178.7 million in Q4 2025 for Hinge Health, down from $208.0 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $208.0 million in Q3 2025 to a low of -$462.6 million in Q2 2024.
  • Historically, Common Equity has averaged -$174.6 million across 3 years, with a median of -$424.0 million in 2023.
  • Biggest five-year swings in Common Equity: decreased 2.49% in 2024 and later skyrocketed 145.04% in 2025.
  • Year by year, Common Equity stood at -$424.0 million in 2023, then dropped by 2.49% to -$434.6 million in 2024, then surged by 141.11% to $178.7 million in 2025.
  • Business Quant data shows Common Equity for HNGE at $178.7 million in Q4 2025, $208.0 million in Q3 2025, and $173.8 million in Q2 2025.